GSK joins a crowd of pharma companies restricting sales under federal program โ Endpoints News
[ad_1] GlaxoSmithKline recently became the 14th biopharma company to switch up its approach to distributing drugs purchased via the federal 340B program for low-income individuals. Effective April 1, GSK said […]






















